EnWave Signs Technology Evaluation And Licence Option Agreement With Major Australian Dairy Company
Jun 25th 18, 06:00
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today that it has signed a Technology Evaluation and License Option Agreement (the “TELOA”) with a major Australian dairy company (the “Partner”) to evaluate the use of the Company’s Radiant Energy Vacuum (“REV™”) technology for the development of several dehydrated, premium dairy ingredients.
The Partner will rent a small-scale REV™ machine for use in Australia for a maximum of six months. During this term, EnWave’s experienced food science team will collaborate closely with the Partner’s innovation group to expedite progress.
EnWave has signed a total of four TELOAs with Australian companies and has granted two separate commercial licenses to Australian royalty partners. Ashgrove Cheese Pty Ltd. has launched a premium, shelf-stable cheese snack line called Amazeballs through IGA, Coles and Woolworths locations in Australia. Howe Foods Pty Ltd. is currently developing several banana-based products for commercial evaluation. Each own small-scale commercial REV™ machines.
EnWave Corporation, a Vancouver-based advanced technology company, has developed Radiant Energy Vacuum (“REV™”) – an innovative, proprietary method for the precise dehydration of organic materials. EnWave has further developed patented and patent-pending methods for uniformly drying biopharmaceutical and pharmaceutical products through the use of REV™ technology, enabling the development of continuous pharmaceutical lyophilization processes.
2. powderREV® which is used for the bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point, and
3. quantaREV® which is used for continuous, high-volume low-temperature drying.
An additional platform, freezeREV®, is being developed as a new method to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.
For further information:
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.